A murine model of prenatal cocaine exposure: Effects on the mother and the fetus

Pharmacology Biochemistry and Behavior

Volumn 55, Issue 4, 1996, Pages 565-574

  Middaugh, Lawrence D ^a   Boggan, William O ^a   Bingel, Sarah A ^a   Patrick, Kennerly S ^b   Xu, Weidong ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

C57BL 6J mice; cocaine pathology; intrauterine growth reduction; prenatal cocaine

Indexed keywords

COCAINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOPAMINERGIC SYSTEM; DRUG BLOOD LEVEL; FEMALE; FETUS; INTRAUTERINE GROWTH RETARDATION; MOUSE; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT GAIN;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMAL NUTRITION PHYSIOLOGY; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; COCAINE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; FETUS; INJECTIONS, SUBCUTANEOUS; INTUBATION, GASTROINTESTINAL; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NARCOTICS; PREGNANCY;

EID: 0030451235     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00250-X     Document Type: Article

References (52)

1. 1. Bonthius, D. J.; Goodlett, C. R.; West, J. R. Blood alcohol concentration and severity of microencephaly in neonatal rats depend on the pattern of alcohol administration. Alcohol 5:209-214; 1988.
2. 2. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248; 1976.
3. 3. Bruckner, J. V.; Jiang, W. D.; Ho, B. T.; Levy, B. M. Histopathological evaluation of cocaine-induced skin lesions in the rat. J. Cutan. Pathol. 9:83-95; 1982.
4. 4. Byrnes, J. J.; Pritchard, G. A.; Koff, J. M.; Miller, L. G. Prenatal cocaine exposure: Decreased sensitization to cocaine and decreased striatal dopamine transporter binding in offspring. Neuropharmacology 32:721-723; 1993.
5. 5. Chasnoff, I. J. Cocaine, pregnancy, and the growing child. Curr. Probl. Pediatr. 22:302-321; 1992.
6. 6. Chasnoff, I. J.; Burns, K. A.; Burns, W. J. Cocaine use in pregnancy: Perinatal morbidity and mortality. Neurotoxicol. Teratol. 9:291-293; 1987.
7. 7. Chasnoff, I. J.; Burns, W. J.; Schnoll, S. H.; Burns, K. A. Cocaine use in pregnancy. N. Engl. J. Med. 313:666-669; 1985.
8. 8. Chasnoff, I. J.; Griffith, D. R.; MacGregor, S.; Dirkes, K.; Burns. K. A. Temporal patterns of cocaine use in pregnancy. JAMA 261:1741-1744; 1989.
9. 9. Church, M. W.; Kaufmann, R. A.; Keenan, J. A.; Martier, S. S.; Savoy-Moore, R. T.; Ostrea, E. M. Jr.; Subramanian, M. G.; Welch, R. A.; Zajac, C. S. Effects of prenatal cocaine exposure. In: Watson, R.R., ed. Biochemistry and physiology of substance abuse, vol. 3. Boca Raton: CRC Press; 1991:179-204.
10. 10. Church, M. W.; Overbeck, G. W. Prenatal cocaine exposure in the long-evans rat: II. Dose-dependent effects on offspring behavior. Neurotoxicol. Teratol. 12:63-71; 1990.
11. 11. Church, M. W.; Rauch, H. C. Prenatal cocaine exposure in the laboratory mouse: Effects on maternal water consumption and offspring outcome. Neurotoxicol. Teratol. 14:313-319; 1992.
12. 12. Dobbing, J. Undernutrition and the developing brain. In: Himwich, W. A., ed. Developmental neurobiology. Springfield, IL: Charles C. Thomas; 1970:241-261.
13. 13. Dow-Edwards, D. L. Long-term neurochemical and neurobehavioral consequences of cocaine use during pregnancy. Ann. N.Y. Acad. Sci. 562:280-289; 1989.
14. 14. Dow-Edwards, D.; Fico, T. A.; Osman, M.; Gamagaris, Z.; Hutchings, D. E. Comparison of oral and subcutaneous routes of cocaine administration on behavior, plasma drug concentration and toxicity in female rats. Pharmacol. Biochem. Behav. 33:167-173; 1989.
15. 15. Dunn, T. B. Normal and pathologic anatomy of the adrenal gland of mouse, including neoplasms. J. Natl. Cancer Inst. 44:1323-1389; 1970.
16. 16. George, F. R.; Elmer, G. L.; Meisch R. A.; Goldberg, S. R. Orally delivered cocaine functions as a positive reinforcer in C57BL/6J mice. Pharmacol. Biochem. Behav. 38:897-903; 1991.
17. 17. Gressens, P.; Kosofsky B. E.; Evrard, P. Cocaine-induced disturbances of corticogenesis in the developing murine brain. Neurosci. Lett. 140:113-116; 1992.
18. 18. Goeders, N. E.; Kuhar, M. J. Chronic cocaine administration induces opposite changes in dopamine receptors in the striatum and nucleus accumbens, Alcohol Drug Res. 7:207-216; 1987.
19. 19. Golden, G. S. Prenatal development of the biogenic amine system of the mouse brain. Dev. Biol. 33:300-311; 1973.
20. 20. Grahame, N. J.; Cunningham, C. L. Genetic differences in intravenous cocaine self-administration between C57BL/6J and DBA/ 2J mice. Psychopharmacology 122:281-291; 1995.
21. 21. Hadfield, M. G.; Milio, C. Cocaine and regional brain monoamines in mice. Pharmacol. Biochem. Behav. 43:395-403; 1992.
22. 22. Henderson, M. G.; McConnaughey, M. M.; McMillen, B.A. Long-term consequences of prenatal exposure to cocaine or related drugs: Effects on rat brain monoaminergic receptors. Brain Res. Bull. 26:941-945; 1991.
23. 23. Henderson, M. G.; McMillen. B. A. Effects of prenatal exposure to cocaine or related drugs on rat developmental and neurological indices. Brain. Res. Bull. 24:207-212; 1990.
24. 24. Heyser, C. J.; Miller, J. S.; Spear, N. E.; Spear, L. P. Prenatal exposure to cocaine disrupts cocaine-induced conditioned place preference in rats. Neurotoxicol. Teratol. 14:57-64; 1992.
25. 25. Hurd, Y. L.; Weiss, F.; Koob, G. F.; And, N-E.; Ungerstedt, U. Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: An in vivo microdialysis study. Brain Res. 498:199-203; 1989.
26. 26. Hutchings, D. E. The puzzle of cocaine's effects following maternal use during pregnancy: Are there reconcilable differences? Neurotoxicol. Teratol. 15:281-286; 1993.
27. 27. Jones, B. C.; Reed, C. L.; Radcliffe, R. A.; Erwin, V. G. Pharmacogenetics of cocaine: I. Locomotor activity and selfselection. Pharmacogenetics 3:182-188; 1993.
28. 28. Koff, J. M.; Miller, L. G. Prenatal cocaine exposure: Increased striatal dopamine transporter binding in offspring at 3 and 6 months of age. Brain Res. Bull. 33:223-224; 1994.
29. 29. Koob, G. F.; Vaccarino, F. J.; Amalric, M.; Swerdlow, N. R. Neural substrates for cocaine and opiate reinforcement. In: Fisher, S.; Raskin, A.; Uhlenhuth, E.H., eds. Cocaine: Clinical and biobehavioral aspects. New York: Oxford University Press; 1987:80-108.
30. 30. Little, B. B.; Snell, L. M. Brain growth among fetuses exposed to cocaine in utero: Asymmetrical growth retardation. Obstet. Gynecol. 77:361-364; 1991.
31. 31. Lookingland, K. J.; Jarry, H. D.; Moore, K. E., The metabolism of dopamine in the median eminence reflects the activity of tuberoinfundibular neurons. Brain Res. 419:303-310; 1987.
32. 32. Meyer, J. S.; Dupont, S. A. Prenatal cocaine administration stimulates fetal brain tyrosine hydroxylase activity. Brain Res. 608:129-137; 1993.
33. 33. Meyer, J. S.; Shearman, L. P.; Collins, L. M.; Maguire, R. L. Cocaine binding sites in fetal rat brain: Implications for prenatal cocaine action. Psychopharmacology 112:445-451; 1993.
34. 34. Middaugh, L. D.; Boggan, W. O. Postnatal growth deficits in prenatal ethanol exposed mice: Characteristics and critical periods. Alcohol. Clin. Exp. Res. 15:919-926; 1991.
35. 35. Miller, S. R.; Middaugh, L. D.; Boggan, W. O.; Patrick, K. S. Cocaine concentrations in fetal C57BL/6 mouse brain relative to maternal brain and plasma. Neurotoxicol. Teratol. 18:1-5: 1996.
36. 36. Moody, C. A.; Frambes, N. A.; Spear, L. P. Psychopharmacological responsiveness to the dopamine agonist quinpirole in normal weanlings and in weanling offspring exposed gestationally to cocaine. Psychopharmacology 108:256-262; 1992.
37. 37. Patrick, K. S.; Boggan, W. O.; Miller, S. R.; Middaugh, L. D. Gas chromatographic-mass spectrometric determination of plasma and brain cocaine in mice. J. Chromatogr. Biomed. Appl. 621:89-94; 1993.
38. 38. Peris, J.; Coleman-Hardee, M.; Millard, W. J. Cocaine in utero enhances the behavioral response to cocaine in adult rats. Pharmacol. Biochem. Behav. 42:509-515; 1992.
39. 39. Pierce, D. R.; West, J. R. Alcohol-induced microencephaly during the third trimester equivalent: Relationship to dose and blood alcohol concentration. Alcohol 3:185-191; 1986.
40. 40. Pierce, D. R.; West, J. R. Blood alcohol concentration: A critical factor for producing fetal alcohol effects. Alcohol 3:269-272; 1986.
41. 41. Pirozhkov, S. V.; Eskelson, C. D.; Watson, R. R. Chronic ethanol and cocaine-induced hepatotoxicity: Effects of Vitamin E supplementation. Alcohol. Clin. Exp. Res. 16:904-909; 1992.
42. 42. Richardson, G. A.; Day, N. L. Maternal and neonatal effects of moderate cocaine use during pregnancy. Neurotoxicol. Teratol. 13:455-460; 1991.
43. 43. Richardson, G. A.; Day, N. L.; Goldschmidt, L. A longitudinal study of prenatal cocaine exposure: 3-year outcome. Neurotoxicol. Teratol. 17:383; 1995.
44. 44. Roberts, S.M.; Roth, L.; Harbison, R. D.; James, R. C. Cocaethylene hepatotoxicity in mice. Biochem. Pharmacol. 43:1989-1995; 1992.
45. 45. Sallee, F. R.; Nesbitt, L.; Katikaneni, L. P.; Ibrahim, H. M.; McArthur, P. D.; Sethuraman, G. Head growth in cocaine-exposed infants: Relationship to neonate hair level. J. Dev. Behav. Pediatr. 16:77-81; 1995.
46. 46. Seale, T. W.; Carney, J. M. Genetic determinants of susceptibility to the rewarding and other behavioral actions of cocaine. In: George, F. R.; Clouet, D., eds. Behavioral and biochemical issues in substance abuse. New York: Haworth Press; 1991:141-162.
47. 47. Shuster, L.; Garhart, C. A.; Powers, J.; Grunfeld, Y.; Kanel, G. Hepatotoxicity of cocaine. In: Clouet, D.; Asghar, K.; Brown, R., eds. Mechanisms of cocaine abuse and toxicity. NIDA Research Monograph 88; 1988:250-275.
48. 48. Spear, L. P.; Kirstein, C. L.; Frambes, N. A. Cocaine effects on the developing CNS: Behavioral, psychopharmacological and neurochemical studies. Ann. N.Y. Acad. Sci. 562:290-307; 1989.
49. 49. Tolliver, B. K.; Carney, J. M. Sensitization to stereotypy in DBA/ 2J but not C57BL/6J mice with repeated cocaine. Pharmacol. Biochem. Behav. 48:169-173; 1994.
50. 50. Tolliver, B. K.; Carney, J. M. Locomotor stimulant effects of cocaine and novel cocaine analogs in DBA/2J and C57BL/6J inbred mice. Pharmacol. Biochem. Behav. 50:163-169; 1995.
51. 51. Volpe, J. J. Effect of cocaine use on the fetus. N. Engl. J. Med. 327:399407; 1992.
52. 52. Zuckerman, B.; Frank, D. A.; Hingson, R.; Amaro, H.; Levenson, S. M.; Kayne, H.; Parker, S.; Vinci, R.; Aboagye, K.; Fried, L. E.; Cabral H.; Timperi, R. Effects of maternal marijuana and cocaine use on fetal growth. N. Engl. J. Med. 320:762-768; 1989.